- Samsung Life Science Fund invests inGenerate:Biomedicines,a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development
12-18
Advances the development and deployment of flagship products Eureka Controller and Eureka 3D Camera Scales operations in Singapore and Japan,and enables full entry in the US market
12-18
HONG KONG,Dec. 12,2024-- On December 12 and 13,the 2024 China Mermaid Open Grand Final and Asian Cup commenced grandly at Atlantis Sanya. As the first Asian Cup for mermaid sports,this event marks a s
12-18
TAIPEI,Dec. 12,2024--Advantech (2395,TW),a leading provider of AIoT platforms and services,proudly unveils its latest AI acceleration modules: the EAI-1200and EAI-3300,powered by Hailo-8™ AI processo
12-18
BEIJING,Dec. 12,2024-- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"),the first U.S.-listed EV charging service company inChina,today announced that Sustainable Fitc
12-18
- A Milestone in Preventive Healthcare and Technological Innovation in Long An TÂN AN CITY,Vietnam,Dec. 12,2024-- Core8 Group,an Australian leader in high-tech and biotech innovation,has unveile
12-18
YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme
12-18
HANOI,Vietnam,Dec. 12,2024--FPT Corporation and SBI Holdings - The leading financial service group in Japan,signed the Memorandum of Understanding,planning to invest in targeting up to 35% of shares o
12-18
TheGlobal X US Treasury 0-3 Month ETF (3440 / 9440)is the first short-term US T-bills ETF listed in Hong Kong
12-18
BANGKOK,Dec. 13,2024-- Kerry,a global leader in taste and nutrition,recently opened an expanded Customer Co-Creation facility in Bang Na,Bangkok,strengthening the company\'s capacity to foster creati
12-18
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
